Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine. (2021)
Attributed to:
A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.cell.2021.10.011
PubMed Identifier: 34735795
Publication URI: http://europepmc.org/abstract/MED/34735795
Type: Journal Article/Review
Volume: 184
Parent Publication: Cell
Issue: 23
ISSN: 0092-8674